Welcome to our dedicated page for PEARSON PLC SEC filings (Ticker: PSORF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on PEARSON PLC's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into PEARSON PLC's regulatory disclosures and financial reporting.
Pearson plc reports that as at close of business on 31 December 2025, it had 635,814,880 ordinary shares of 25p each admitted to trading. Each ordinary share carries one vote at general meetings, and the company holds no shares in treasury. This total share count is the denominator shareholders should use when calculating whether they must notify the regulator of their ownership or any changes, in line with the FCA's Disclosure and Transparency Rules.
Pearson plc filed a report disclosing a share purchase by one of its board members. Non-Executive Director Arden Hoffman bought 875 American Depositary Receipts (ADRs) in Pearson plc on 10 December 2025. Each ADR represents one ordinary share of 25 pence in Pearson plc. The ADRs were purchased on the New York Stock Exchange at a price of $13.63 per ADR, for an aggregated amount of $11,926.25. This is a standard disclosure of a transaction by a person discharging managerial responsibilities.
Pearson plc reports that an investor linked to Cevian Capital has increased its stake and now holds 14.174888% of the company’s voting rights, representing 90,120,099 voting rights attached to shares. This is up from a previous holding of 13.048636% of voting rights. The position is held through Aurora Nominees Limited, with Cevian Capital II G.P. Limited identified as the ultimate controlling person and Cevian Capital II Master Fund L.P. as the controlled undertaking. The notification confirms that the stake is held entirely through ordinary shares with ISIN GB0006776081 and that no additional voting rights are held through financial instruments.
Cevian Capital II GP Limited has filed Amendment No. 9 to its Schedule 13D, reporting a large ownership position in Pearson plc. The reporting person beneficially owns 90,182,758 ordinary shares, representing 14.18% of Pearson’s ordinary shares, based on 635,772,938 shares outstanding as of November 30, 2025. Cevian has sole voting and sole dispositive power over all of these shares.
The filing states that these shares were acquired for the account of the Master Fund for total consideration of approximately USD $705,680,181, using British pounds and a conversion rate of USD 1.33425 per GBP 1.00. The purchases were funded from the Master Fund’s general working capital, indicating a substantial capital commitment to Pearson’s ordinary shares.
Pearson plc reported a governance update involving its board committees. The company announced that non-executive director Costis Maglaras will join both the Audit Committee and the Reputation & Responsibility Committee, effective 1 January 2026. This change reflects an adjustment in committee membership rather than an operational or financial development, and the notification is made in line with UK listing rules.
Pearson plc reports its current voting share capital for regulatory purposes. As at close of business on 30 November 2025, the company had 635,772,938 ordinary shares of 25p each admitted to trading, and each ordinary share carries one vote at general meetings. Pearson holds no shares in treasury, meaning all these shares currently represent voting rights. The company explains that the total of 635,772,938 shares may be used by shareholders as the denominator when calculating whether they must notify the UK Financial Conduct Authority of any holdings or changes under the Disclosure and Transparency Rules.
Pearson plc filed a foreign issuer report outlining activity under its employee share schemes for the period from 1 June 2025 to 30 November 2025. Under the Save for Shares Plan, 846,779 securities were issued or allotted, reducing the balance of unallotted securities from 2,328,888 to 1,482,109. Under the Employee Stock Purchase Plan, the block was increased by 1,700,000 securities, with 234,493 issued or allotted during the period, resulting in 2,228,992 securities remaining unallotted at the end of the period. The filing is an administrative update on share plan usage and available headroom under these schemes.
Pearson plc reported an update to its voting rights and share capital. As at close of business on 31 October 2025, the company had 640,181,375 ordinary shares of 25p each admitted to trading. Each ordinary share entitles the holder to one vote at general meetings. The company holds no shares in Treasury. Pearson noted that 640,181,375 may be used by shareholders as the denominator for FCA Disclosure and Transparency Rule calculations.
Pearson plc reported a PDMR share purchase on a Form 6-K. Chair Omid Kordestani bought 6,746 Pearson American Depositary Receipts (ADRs) at $14.065 per ADR, for an aggregate of $94,882.49.
The transaction took place on 30 October 2025 on the New York Stock Exchange (XNYS). Each ADR represents one ordinary share of 25 pence in Pearson plc (ISIN: US7050151056).
Pearson plc appointed Costis Maglaras as an independent Non-Executive Director, effective 1 November 2025. Maglaras is the Dean of Columbia Business School and a professor focused on how emerging technologies shape business, bringing experience across AI, neural networks, machine vision, blockchain, and robotics.
Pearson’s Chair, Omid Kordestani, welcomed the appointment, highlighting Maglaras’s blend of academic and technology expertise as the company advances its strategy. Maglaras, who has been with Columbia Business School since 1998 and has consulted at Goldman Sachs, Bank of America, and Mismi Inc., emphasized aligning learning and skilling with rapid changes in the global business landscape. The company noted there is no further information to be declared in accordance with UKLR 6.4.8.